Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ra Pharmaceuticals Inc (RARX)

Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ra Pharmaceuticals Inc 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 USA

www.rapharma.com P: 617-401-4060

Description:

Ra Pharmaceuticals, Inc. is a biopharmaceutical company. It involved in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Ra Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 2,271,555
Shares Outstanding, K 47,329
Annual Sales, $ 3,000 K
Annual Net Income, $ -102,690 K
Last Quarter Sales, $ 3,000 K
Last Quarter Net Income, $ -24,980 K
60-Month Beta 1.04
% of Insider Shareholders 4.30%
Float, K 45,294
% Float 95.70%

Growth:

1-Year Return 130.86%
3-Year Return 123.13%
5-Year Return 0.00%
5-Year Revenue Growth -37.89%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/14/20
Earnings Per Share ttm -1.99
EPS Growth vs. Prev Qtr -43.64%
EPS Growth vs. Prev Year -68.09%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RARX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.61%
Return-on-Assets % -41.60%
Profit Margin % -3,423.00%
Debt/Equity 0.01
Price/Sales 757.42
Price/Cash Flow N/A
Price/Book 8.63
Book Value/Share 6.25
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar